Study of the comorbidities in hospitalized patients due to decompensated chronic obstructive pulmonary disease attended in the Internal Medicine Services. ECCO Study

被引：22

作者：

Almagro, P. ^{[1
]}

Lopez Garcia, F. ^{[2
]}

Cabrera, F. J. ^{[3
]}

Montero, L. ^{[4
]}

Morchon, D. ^{[5
]}

Diez, J. ^{[6
]}

de la Iglesia, F. ^{[7
]}

Roca, F. B. ^{[8
]}

Fernandez-Ruiz, M. ^{[9
]}

Castiella, J. ^{[10
]}

Zubillaga, E. ^{[11
]}

Recio, J. ^{[12
]}

Soriano, J. B. ^{[13
]}

机构：

[1] Hosp Mutua Terrassa, Med Interna Serv, Barcelona, Spain

[2] Hosp Vega Baja Orihuela, Med Interna Serv, Alicante, Spain

[3] Univ Gregorio Maranon, Med Interna Serv, Gen Hosp, Madrid, Spain

[4] Hosp Comarcal Axarquia, Med Interna Serv, Malaga, Spain

[5] Hosp Univ Rio Hortega, Med Interna Serv, Valladolid, Spain

[6] Hosp Royo Villanova, Med Interna Serv, Zaragoza, Spain

[7] Hosp Juan Canalejo, Med Interna Serv, La Coruna, Spain

[8] Hosp Gen Castellon, Med Interna Serv, Castellon de La Plana, Spain

[9] Hosp Gen Univ 12 Octubre, Med Interna Serv, Madrid, Spain

[10] Fdn Hosp Calahorra, Med Interna Serv, La Rioja, Spain

[11] Hosp Donostia, Med Interna Serv, San Sebastian, Spain

[12] Univ Vall Hebron, Med Interna Serv, Gen Hosp, Barcelona, Spain

[13] Ctr Int Med Resp Avanzada, Fdn Caubet Cimera, Bunyola, Mallorca, Spain

来源：

REVISTA CLINICA ESPANOLA | 2010年 / 210卷 / 03期

关键词：

Chronic obstructive pulmonary disease; Comorbidity; Hospitalization; Cardiac failure; Myocardical ischemia; Diabetes mellitus; Arterial hypertension; CARDIOVASCULAR-DISEASE; COPD; MORTALITY; PREVALENCE; DYSPNEA; INDEX; EXACERBATION; DYSFUNCTION; MANAGEMENT; SURVIVAL;

D O I：

10.1016/j.rce.2009.12.002

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

Objective: Evaluate comorbidity in patients hospitalized due to COPD in the Internal Medicine services. Methods: An observational, prospective and multicenter study. The Charlson index and a specific questionnaire were used. Results: A total of 398 patients, 353 men (89%), with mean age of 73.7 years (8.9) and mean FEV, of 43.2% (12.5), were included. The most frequent comorbidities were: arterial hypertension (55%), arrhythmias (27%) and diabetes mellitus (26%). A total of 27% suffered heart failure, 17% coronary disease and 9% previous myocardial infarction. The number of associated chronic diseases was 3.6 (1,8). Score on Charlson index was 2.72 (2). Conclusions: The patients hospitalized due to decompensated COPD had an elevated comorbidity. (C) 2009 Elsevier Espana, S.L. All rights reserved.

引用

页码：101 / 108

页数：8

共 34 条

[1]

Association of left-heart dysfunction with severe exacerbation of chronic obstructive pulmonary disease - Diagnostic performance of cardiac biomarkers [J].

Abroug, Fekri ;

Ouanes-Besbes, Lamia ;

Nciri, Noureddine ;

Sellami, Noura ;

Addad, Faouz ;

Ben Hamda, Khaldoun ;

Ben Amor, Adel ;

Najjar, Mohamed F. ;

Knani, Jalel .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 174 (09) :990-996

[2]

Mortality after hospitalization for COPD [J].

Almagro, P ;

Calbo, E ;

de Echagüen, AO ;

Barreiro, B ;

Quintana, S ;

Heredia, JL ;

Garau, J .

CHEST, 2002, 121 (05) :1441-1448

[3]

[Anonymous], 2008, GLOB STRAT DIAGN MAN

[4]

ANTIBIOTIC-THERAPY IN EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY-DISEASE [J].

ANTHONISEN, NR ;

MANFREDA, J ;

WARREN, CPW ;

HERSHFIELD, ES ;

HARDING, GKM ;

NELSON, NA .

ANNALS OF INTERNAL MEDICINE, 1987, 106 (02) :196-204

[5]

Long-term mortality follow-up of the ISOLDE participants: Causes of death during 13 years after trial completion [J].

Bale, Geraldine ;

Martinez-Camblor, Pablo ;

Burge, P. Sherwood ;

Soriano, Joan B. .

RESPIRATORY MEDICINE, 2008, 102 (10) :1468-1472

[6]

Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease [J].

Bestall, JC ;

Paul, EA ;

Garrod, R ;

Garnham, R ;

Jones, PW ;

Wedzicha, JA .

THORAX, 1999, 54 (07) :581-586

[7]

International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study [J].

Buist, A. Sonia ;

McBurnie, Mary Ann ;

Vollmer, William M. ;

Gillespie, Suzanne ;

Burney, Peter ;

Mannino, David M. ;

Menezes, Ana M. B. ;

Sullivan, Sean D. ;

Lee, Todd A. ;

Weiss, Kevin B. ;

Jensen, Robert L. ;

Marks, Guy B. ;

Gulsvik, Amund ;

Nizankowska-Mogilnicka, Ewa .

LANCET, 2007, 370 (9589) :741-750

[8]

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease [J].

Calverley, Peter M. A. ;

Anderson, Julie A. ;

Celli, Bartolome ;

Ferguson, Gary T. ;

Jenkins, Christine ;

Jones, Paul W. ;

Yates, Julie C. ;

Vestbo, Jorgen ;

Calverley, P. M. A. ;

Anderson, J. A. ;

Celli, B. ;

Ferguson, G. T. ;

Jenkins, C. ;

Jones, P. W. ;

Knobil, K. ;

Yates, J. C. ;

Vestbo, J. ;

Cherniack, R. ;

Similowski, T. ;

Cleland, J. ;

Whitehead, A. ;

Wise, R. ;

McGarvey, L. ;

John, M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (08) :775-789

[9]

The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease [J].

Celli, BR ;

Cote, CG ;

Marin, JM ;

Casanova, C ;

de Oca, MM ;

Mendez, RA ;

Pinto Plata, V ;

Cabral, HJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (10) :1005-1012

[10]

VALIDATION OF A COMBINED COMORBIDITY INDEX [J].

CHARLSON, M ;

SZATROWSKI, TP ;

PETERSON, J ;

GOLD, J .

JOURNAL OF CLINICAL EPIDEMIOLOGY, 1994, 47 (11) :1245-1251

← 1 2 3 4 →